Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial

BACKGROUND: Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There has been recent interest in the use of hypofractionated radiotherapy in treating prostate cancer. However, toxicity and cancer ou...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Mendez, Lucas C., Arifin, Andrew J., Bauman, Glenn S., Velker, Vikram M., Ahmad, Belal, Lock, Michael, Venkatesan, Varagur M., Sexton, Tracy L., Rodrigues, George B., Chen, Jeff, Schaly, Bryan, Warner, Andrew, D’Souza, David P.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547418/
https://ncbi.nlm.nih.gov/pubmed/33036579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07490-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky